FEB 15, 2020 1:57 AM PST

FDA nod for AI-powered technology to detect strokes

WRITTEN BY: Tara Fernandez

The US Food and Drug Administration (FDA) has provided clearance for a novel technology that uses artificial intelligence (AI) to detect strokes. The platform was designed and developed by Aidoc, which has three other FDA-approved systems for diagnosing various acute and chronic conditions in the spine, abdomen, and chest.

The vast majority of strokes are ischaemic, which occurs as a result of a blood clot blocking the flow of blood to the brain. Strokes can also be hemorrhagic in nature when a blood vessel in the brain ruptures. During a stroke, the brain is deprived of oxygen, causing huge numbers of neurons in the affected area to die within minutes. Signs of a stroke include slurred speech, paralysis in one side of the body and loss of coordination.

Elevated blood pressure is a significant risk factor associated with having a stroke, with smoking, obesity, diabetes, and high cholesterol also contributing to an increased risk. In 2015, it was estimated that there were over 42 million stroke survivors worldwide, indicating the sheer extent of the global medical burden from this disease.

Aidoc’s AI-driven system aims to lessen the impact of strokes by diagnosing them faster and more accurately than conventional clinical protocols. Here, the software is capable of identifying both classes of strokes from computerized tomography (CT) scan data, automatically putting suspected cases at the top of radiologists’ worklists, such that medical attention is rendered sooner for these critical patients.

The advent of AI-powered assistive technologies has not always been met with open arms by radiologists and physicians, with many doubting its ability to navigate complex clinical practices and expertise that can only be gained by years of work with patients. However, these platforms are not intended to replace clinical practitioners, but instead to be used as a tool to simplify and accelerate their workloads. Research has found that many radiologists have unrealistic volumes of scans to attend to on a daily basis, requiring them to look at images every three seconds for eight hours a day just to complete their massive quotas.

However, when it comes to strokes, time is of the essence and delayed diagnoses can have permanent, debilitating long-term consequences on patients.

“Stroke is the ultimate time-critical condition. The faster we can identify, diagnose and treat it, the better the outcome for patients,” says Dr. Marcel Maya, co-chair of Cedars-Sinai Medical Center’s Department of Imaging.

Speaking on Aidoc’s diagnostic system he adds, “Aidoc’s comprehensive stroke package flags both large vessel occlusion and hemorrhages inside our existing workflows, ensuring we can diagnose stroke faster and decide on the best course of treatment. We’re already seeing how this has a positive impact on department efficiency and patient length of stay.”

 


Sources: Medical Device Network, Aidoc.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
SEP 02, 2019
Clinical & Molecular DX
SEP 02, 2019
A Blood Drop Test for Rapid Detection of Traumatic Brain Injury
A study published by Yue et al., in August 2019, reported that a simple blood test (a few drops of blood) can detect traumatic brain injury efficiently and...
NOV 05, 2019
Cannabis Sciences
NOV 05, 2019
Single Exposure to CBD & THC Disrupts Embryonic Development
It only takes one incidence of cannabinoid exposure during the first month of pregnancy to yield detrimental effects on a developing embryo. New research r...
NOV 25, 2019
Clinical & Molecular DX
NOV 25, 2019
eRapid: molecular diagnostic power in the palm of your hand
We've heard lofty biotech promises in the news of being able to diagnose diseases from a single drop of blood. Yet, diagnostic procedures for the maj...
NOV 14, 2019
Chemistry & Physics
NOV 14, 2019
Examining the Squirrelly Ones: Wearable MEG Scanner that Suits Pediatric Patients
In a recent study, a joint research team at the University of Nottingham, University of Oxford, and University College London successfully tested a ne...
DEC 18, 2019
Clinical & Molecular DX
DEC 18, 2019
Germs don't stand a chance with new AI-powered diagnostic platform
We are steadily losing our edge in the war against infectious bacteria. A huge surge in antibiotic resistance is threatening healthcare and agricultural in...
FEB 24, 2020
Clinical & Molecular DX
FEB 24, 2020
Nanoparticles provide momentum for better diagnostic imaging
Photoacoustic imaging is an emerging tool with a vast array of biomedical applications ranging from the detection of brain lesions to imaging early signs o...
Loading Comments...